FindMyKOL

Robert Derick, MD

Basic profile

The Ohio State University

ORCIDNone on fileNPI↗
✓ Full record
RegionLima, OH · MidwestSpecialtyOphthalmologyFocusOphthalmology
Active KOLFindMyKOL type: RegionalLatest publication2014Online presenceNot yet checkedPayments2021 onwardNIH funding1994–1999Why? →

Robert Derick is an Ophthalmology physician affiliated with The Ohio State University. OpenAlex indexes 19 publications with 1,332 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
19publications

Distinct works indexed by OpenAlex.

1,332citations

Total citations across indexed works.

12h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
9companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 1994–1999

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

855 W Market St
Ste A
Lima, OH 45805

Telephone

419-228-7432

Registry record last updated 8 Jul 2007.

View the NPPES registry record

Industry payments

9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    67.5%
    Prostaglandin Analog38.5%
    Latanoprost94%Lumigan3%Travoprost3%
    Part D≥261 patients
    Corticosteroid11.2%
    Prednisolone Acetate96%Fluorometholone4%
    Part D<11 patients

    + 3 more classes in this area

  • Cardiovascular

    29.9%
    Beta blocker29.9%
    Timolol Maleate100%
    Part D≥257 patients
  • Musculoskeletal

    1.3%
    Cyclooxygenase Inhibitor1.3%
    Ketorolac Tromethamine100%
    Part D≥12 patients
Where care is delivered (Part B)9.1% facility · 90.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 1994–1999 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

All 17 publications: search, sort and filter.Explore →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”